Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Posts tagged Torrent Pharma

Why Does Sanjoy Bhattacharyya Call His Latest Stock Pick J&K Bank “Incredibly Attractive”?



Sanjoy Bhattacharyya, the doyen amongst value investors, has selected J&K Bank as his latest stock pick and called it “incredibly attractive”. As usual, the veteran investor has given convincing reasons for his stock recommendation

Why Is Ashish Dhawan’s ChrysCapital So Bullish On Mid-Cap Pharma Stocks?



ChrysCapital’s recent purchases of big stakes in two mid-cap pharma stocks sends the clear message that Pharma stocks is where the action is at present

Sanjoy Bhattacharyya’s Portfolio Picks For Ocean Dial’s “Gateway to India Fund”



Sanjoy Bhattacharyya, the veteran value investor, has been appointed “Fund Adviser” to the $23 Million Ireland based fund. We peep in to see what stocks he has recommended for the fund

Newer Entries →

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 509 other subscribers

RSS Stocks Talk Forum

  • Raymond Lifestyle has multiple growth drivers. Target Price ₹3000 (+49%)
    Raymond Lifestyle has multiple growth drivers. It boasts legacy of established brands such as Park Avenue. However brands remain under-penetrated due to sluggish execution in past. Renewed focus on growth could lead to valuation re-rating. TP ₹3000 (+49%) Download research report... Raymond Lifestyle has multiple growth drivers. Target Price ₹3000 (+49%)
  • Sunil Singhania's Abakkus has bought 10.69L shares of Aarti Pharma at ₹575 for ₹61.5 Cr
    Sunil Singhania's Abakkus has bought 10.69L shares of Aarti Pharma at ₹575 for ₹61.5 Cr. M-Cap is ₹5800 Cr. Promoters hold 46%. Co operates in 3 areas i.e. Xanthine derivatives, API & CDMO/CMO. It is largest Indian manufacturer of Xanthines & has Global market share of 15-20% ... Sunil Singhania's Abakkus has bought 10.69L shares […]
  • PNB Housing is undergoing a transformation to morph into a franchise that will be stronger
    PNB Housing is undergoing a transformation to morph into a franchise that will be stronger, more resilient & with high predictability in earnings trajectory. Risk-reward profile is favorable for a long-term investor. Buy for TP of ₹1160 (38% upside) Download research... PNB Housing is undergoing a transformation to morph into a franchise that will be […]
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!